Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Linker-dependent variations in the tumoricidal activity of DZ-1-dihydroartemisinin conjugate formats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 20, 2026
Operationalizing patient flow in high-complexity service lines: a health system perspective using oncology care.
Journal: Frontiers in health services
Published: April 18, 2026
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: March 23, 2026
Real-world evidence on data quality in precision oncology platforms: insights from the Molecular Twin Research Umbrella protocol.
Journal: Frontiers in digital health
Published: March 11, 2026
A model psychosocial-spiritual oncology and cancer supportive care services program: Framework and implementation.
Journal: Journal of psychosocial oncology
Published: January 18, 2026
Tumoricidal efficacy of DZ-1 dye conjugated to dihydroartemisinin in patient-derived colorectal liver metastasis tumoroids.
Journal: Molecular therapy. Oncology
Published: January 10, 2026
DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids.
Journal: Frontiers in pharmacology
Published: November 10, 2025
Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2025
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study.
Journal: The Lancet. Oncology
Published: August 19, 2024
Disparities With Systemic Therapies for Black Men Having Advanced Prostate Cancer: Where Do We Stand?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 27, 2023
Genetic and biological drivers of prostate cancer disparities in Black men.
Journal: Nature reviews. Urology
Published: October 05, 2023
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 05, 2023
Last Updated: 09/26/2026